ATE402157T1 - Verfahren zur herstellung von mycophenolatmofetil - Google Patents

Verfahren zur herstellung von mycophenolatmofetil

Info

Publication number
ATE402157T1
ATE402157T1 AT04765061T AT04765061T ATE402157T1 AT E402157 T1 ATE402157 T1 AT E402157T1 AT 04765061 T AT04765061 T AT 04765061T AT 04765061 T AT04765061 T AT 04765061T AT E402157 T1 ATE402157 T1 AT E402157T1
Authority
AT
Austria
Prior art keywords
mycophenolate mofetil
products
relates
producing
dimeric
Prior art date
Application number
AT04765061T
Other languages
English (en)
Inventor
Julia Greil
Johannes Ludescher
Siegfried Wolf
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE402157T1 publication Critical patent/ATE402157T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04765061T 2003-09-11 2004-09-10 Verfahren zur herstellung von mycophenolatmofetil ATE402157T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AT14332003 2003-09-11
AT20292003 2003-12-17
AT20302003 2003-12-17
PCT/EP2004/010134 WO2005023791A2 (en) 2003-09-11 2004-09-10 Process for the production of mycophenolate mofetil

Publications (1)

Publication Number Publication Date
ATE402157T1 true ATE402157T1 (de) 2008-08-15

Family

ID=34279103

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04765061T ATE402157T1 (de) 2003-09-11 2004-09-10 Verfahren zur herstellung von mycophenolatmofetil

Country Status (8)

Country Link
US (1) US20070032483A1 (de)
EP (1) EP1667987B1 (de)
AT (1) ATE402157T1 (de)
CA (1) CA2537958C (de)
DE (1) DE602004015310D1 (de)
ES (1) ES2308226T3 (de)
PL (1) PL1667987T3 (de)
WO (1) WO2005023791A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7683188B2 (en) * 2004-04-26 2010-03-23 TEVA Gyógyszergyár Zártkōrūen Mūkōdō Részvénytársaság Process for preparation of mycophenolic acid and ester derivatives thereof
EP2032712B1 (de) * 2006-06-29 2010-02-10 Ivax Pharmaceuticals S.R.O. Regulation der säuremetabolitproduktion
WO2008003637A2 (en) * 2006-07-05 2008-01-10 Dsm Ip Assets B.V. Isolation and use of amine salts of mycophenolic acid
US20080188653A1 (en) 2007-02-04 2008-08-07 Formosa Laboratories, Inc. Process for Preparation of Mycophenolate Mofetil
WO2008127663A1 (en) * 2007-04-11 2008-10-23 Teva Gyógyszergyár Zártköruen Muködo Részvénytársaság Method for reducing impurity level in mycophenolic acid fermentation
WO2009040828A1 (en) * 2007-09-25 2009-04-02 Biocon Limited A process for purification of mycophenolic acid

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173942A (en) * 1967-06-06 1969-12-10 Bellon Labor Sa Roger New 2,3-Dihydro-1,4-Benzoxazines
JPS5542995B2 (de) * 1972-02-24 1980-11-04
US3868454A (en) * 1972-08-14 1975-02-25 Lilly Co Eli Psoriasis treatment with mycophenolic acid derivatives
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
US4686234A (en) * 1985-11-27 1987-08-11 Syntex (U.S.A) Inc. Mycophenolic acid derivatives in the treatment of inflammatory diseases, in particular rheumatoid arthritis
US4727069A (en) * 1987-01-30 1988-02-23 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof and pharmaceutical compositions
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US5247083A (en) * 1992-07-10 1993-09-21 Syntex (U.S.A.) Inc. Direct esterification of mycophenolic acid
BR9407469A (pt) * 1993-09-15 1996-11-12 Syntex Inc Micofenolato mofetil anidro cristalino e formulação intravenosa do mesmo
US5493030A (en) * 1994-02-18 1996-02-20 Syntex (U.S.A.) Inc. 5-substituted derivatives of mycophenolic acid
IN188985B (de) * 1998-12-09 2002-11-30 Biocon Ltd
CZ292123B6 (cs) * 2001-06-08 2003-08-13 Ivax Pharmaceuticals S.R.O. Způsob přípravy mykofenolátu mofetilu
EP1539693B9 (de) * 2002-06-19 2008-10-08 Schering Corporation Agonisten des cannabinoidrezeptors

Also Published As

Publication number Publication date
EP1667987B1 (de) 2008-07-23
US20070032483A1 (en) 2007-02-08
PL1667987T3 (pl) 2009-01-30
CA2537958C (en) 2013-06-11
WO2005023791A2 (en) 2005-03-17
WO2005023791A3 (en) 2005-11-17
CA2537958A1 (en) 2005-03-17
DE602004015310D1 (de) 2008-09-04
ES2308226T3 (es) 2008-12-01
EP1667987A2 (de) 2006-06-14

Similar Documents

Publication Publication Date Title
MY142926A (en) Method of the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
FI109023B (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
ATE423778T1 (de) Verfahren zur herstellung von anthranilsäurederivat-hydrat
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
DE602004015310D1 (de) Verfahren zur herstellung von mycophenolatmofetil
ATE521600T1 (de) Verfahren zur herstellung von statinen
DK1761478T3 (da) En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder
DE50307171D1 (de) Verfahren zur herstellung von 3-amidinophenylalanin-derivaten
DE50306068D1 (de) Verfahren zum herstellen von salzen des tolperison
WO2004085348A3 (en) Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone
PL1670745T3 (pl) Sposób wytwarzania dinitrotoluenu, w którym jako materiał wyjściowy wykorzystuje się ekstrakty zawierające nitrokrezole
ATE370950T1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
UA89037C2 (ru) Способ получения кислотно-аддитивной соли венлафаксина
DE602006015241D1 (de) Verbessertes verfahren zur herstellung von rivastigmin
DE50002865D1 (de) Verfahren zur herstellung von benzofuranonoximen
ITMI20040582A1 (it) Processo per la semisintesi di deserpidina
ATE501145T1 (de) Narkotinreinigungsverfahren
ATE457304T1 (de) Verfahren zur herstellung von 1,2-dichlorethan freien kristallen von zonisamid und hochreinezonisamidkristalle
DE502005003019D1 (de) Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten
DE602005016857D1 (de) Verfahren zur Herstellung von Tripeptid-Zwischenprodukten zur Herstellung von LHRH-Antagonisten
DE60327813D1 (de) Verfahren zu herstellung von lovastatin.
ATE502045T1 (de) Verfahren zur herstellung von perindoprilerbumin
ATE267167T1 (de) Verfahren zur herstellung von 7-azabicyclo (4.1.0)-hept-3-ene-3-carbonsäureestern
ATE334127T1 (de) Technisches verfahren zur herstellung von tropenol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties